Uptake Medical Raises Series C

Tustin-based Uptake Medical, the developer of treatments for emphysema led by R. King Nelson, announced today that it has raised a Series C funding round. Size of the round was not announced. The round was led by Crescent Point Group (Singapore), along with existing investors Maverick Capital, ONSET Ventures, GBS Venture Partners, WRF Capital, Arboretum Ventures and Affinity Capital. As part of the funding, Sami Sindi of Crescent Point joins the company's board. Uptake said it was assisted by Moelis & Company in the funding round. A recent regulatory filing by Uptake indicates the round was worth at least $35.1M, with a target size of $41.6M. More information »